Effect of SGLT2 inhibitor on patients with STEMI complicated with type 2 diabetes mellitus after PCI
Objective To evaluate the effect of sodium-glucose cotransporter-2 inhibitor (SGLT2i) on the efficacy and safety of percutaneous coronary intervention (PCI) in patients with acute ST segment elevation myocardial infarction (STEMI) complicated with type 2 diabetes mellitus. Methods Four hundred and s...
Main Author: | Du Shengli, Jia Zengqin, Zhang Qihua |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of New Medicine
2023-04-01
|
Series: | Xin yixue |
Subjects: | |
Online Access: | https://www.xinyixue.cn/fileup/0253-9802/PDF/1683603372342-83920489.pdf |
Similar Items
-
Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus
by: Yuta Suzuki, et al.
Published: (2022-05-01) -
Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
by: Panagiotis Theofilis, et al.
Published: (2023-02-01) -
The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study
by: Mateus Paiva Marques Feitosa, et al.
Published: (2023-06-01) -
The Effects of SGLT2 Inhibitors on Lipid Metabolism
by: Zsolt Szekeres, et al.
Published: (2021-02-01) -
Impact of SGLT-2 inhibitors on modifiable cardiovascular risk factors in Romanian patients with type 2 diabetes mellitus
by: Adriana Gherbon, et al.
Published: (2024-04-01)